New method for early detection of multi-cancers based on human metabolism

bySwedish Research CouncilValidation of the pruned combined free GAGome MCED score. (A) Validation study subject flow (see also SI Appendix, Fig. S17). (B) Pruned combined free GAGome MCED score

Updated on: December 25,2023

New method for early detection of multi-cancers based on human metabolism

bySwedish Research CouncilValidation of the pruned combined free GAGome MCED score. (A) Validation study subject flow (see also SI Appendix, Fig. S17). (B) Pruned combined free GAGome MCED score

Updated on:December 25,2023

Patient step counts predict lung cancer treatment outcomes, study finds

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainNumerous studies have shown that monitoring physical activity promotes better health—from reducing body mass index to watching f

Updated on: December 20,2023

Patient step counts predict lung cancer treatment outcomes, study finds

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainNumerous studies have shown that monitoring physical activity promotes better health—from reducing body mass index to watching f

Updated on:December 20,2023

National prostate cancer trial currently testing therapy based on molecular discovery

byCleveland ClinicCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI163498A new prostate cancer therapy in clinical trials could treat patients resistant to treatment t

Updated on: December 23,2023

National prostate cancer trial currently testing therapy based on molecular discovery

byCleveland ClinicCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI163498A new prostate cancer therapy in clinical trials could treat patients resistant to treatment t

Updated on:December 23,2023

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Updated on: January 04,2024

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Updated on:January 04,2024

A treatment for metastasis? Using ferroptosis to attack migrating cancer cells

byFriedrich–Alexander University Erlangen–NurnbergZeb1 regulates the expression of enzymes crucial for adjusting the PUFA:MUFA ratio in phospholipids. Credit:Nature Cell Biology(2024

Updated on: July 17,2024

A treatment for metastasis? Using ferroptosis to attack migrating cancer cells

byFriedrich–Alexander University Erlangen–NurnbergZeb1 regulates the expression of enzymes crucial for adjusting the PUFA:MUFA ratio in phospholipids. Credit:Nature Cell Biology(2024

Updated on:July 17,2024

Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

by Elana GotkineFor patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative co

Updated on: December 28,2023

Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

by Elana GotkineFor patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative co

Updated on:December 28,2023

CAR-T Therapy Under Scrutiny: The Emerging Risk of Secondary Malignant Tumors

CAR-T therapy has long been an effective treatment for hematological cancers such as leukemia and lymphoma. However, some patients have developed secondary malignant tumors after undergoing CAR-T ......

Updated on: May 29,2024

CAR-T Therapy Under Scrutiny: The Emerging Risk of Secondary Malignant Tumors

CAR-T therapy has long been an effective treatment for hematological cancers such as leukemia and lymphoma. However, some patients have developed secondary malignant tumors after undergoing CAR-T ......

Updated on:May 29,2024

Melanoma misconception: Dark skin tones at risk, too

by Sonya GoinsCredit: Unsplash/CC0 Public DomainThe myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It's a dangerous misconception that

Updated on: January 10,2024

Melanoma misconception: Dark skin tones at risk, too

by Sonya GoinsCredit: Unsplash/CC0 Public DomainThe myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It's a dangerous misconception that

Updated on:January 10,2024

Metabolic adaptation ensures survival of colon cancer cells

byGerman Cancer Research CenterCredit: CC0 Public DomainColon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to

Updated on: December 22,2023

Metabolic adaptation ensures survival of colon cancer cells

byGerman Cancer Research CenterCredit: CC0 Public DomainColon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to

Updated on:December 22,2023

Immune cells trained to hunt tumors after scientists plant synthetic 'flags' on cancer

Updated on: June 15,2025

Immune cells trained to hunt tumors after scientists plant synthetic 'flags' on cancer

Updated on:June 15,2025

Mobile 'Man Van' spots prostate cancer more quickly and cheaply than via GPs

byInstitute of Cancer ResearchCredit: The Man Van and The Royal Marsden NHS Foundation TrustMobile testing "Man Van" can diagnose prostate cancer in at-risk groups earlier and more aff

Updated on: December 01,2024

Mobile 'Man Van' spots prostate cancer more quickly and cheaply than via GPs

byInstitute of Cancer ResearchCredit: The Man Van and The Royal Marsden NHS Foundation TrustMobile testing "Man Van" can diagnose prostate cancer in at-risk groups earlier and more aff

Updated on:December 01,2024

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

byEuropean Society for Medical OncologyLead author Barbara Pistilli, a medical oncologist at Institut Gustave Roussy, Villejuif, France. Credit: European Society for Medical OncologyNearly one i

Updated on: December 18,2023

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

byEuropean Society for Medical OncologyLead author Barbara Pistilli, a medical oncologist at Institut Gustave Roussy, Villejuif, France. Credit: European Society for Medical OncologyNearly one i

Updated on:December 18,2023